Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Anesthesiology
Volume 2014 (2014), Article ID 650310, 3 pages
http://dx.doi.org/10.1155/2014/650310
Case Report

Anaesthetic Management of Two Patients with Pompe Disease for Caesarean Section

Department of Anesthesiology, Erasmus MC-Sophia, Postbus 2060, 3000 CB Rotterdam, The Netherlands

Received 15 January 2014; Accepted 12 February 2014; Published 20 March 2014

Academic Editors: M. Dauri, Y. Demiraran, and C. Seefelder

Copyright © 2014 I. J. J. Dons-Sinke et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. S. Kishani, R. D. Steiner, D. Bali et al., “Pompe disease diagnosis and management guideline,” Genetics in Medicine, vol. 8, pp. 267–288, 2006. View at Google Scholar
  2. M. G. E. M. Ausems, J. Verbiest, M. M. P. Hermans et al., “Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling,” European Journal of Human Genetics, vol. 7, no. 6, pp. 713–716, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Y. Wang, O. A. Bodamer, M. S. Watson, and W. R. Wilcox, “Lysosomal storage diseases: diagnostic confirmation and management of presymptomatic individuals,” Genetics in Medicine, vol. 13, no. 5, pp. 457–484, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. D. L. Bernstein, M. G. Bialer, L. Mehta, and R. J. Desnick, “Pompe disease: dramatic improvement in gastrointestinal function following enzyme replacement therapy: a report of three later-onset patients,” Molecular Genetics and Metabolism, vol. 101, no. 2-3, pp. 130–133, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Remiche, A. G. Herbaut, D. Ronchi et al., “Incontinence in late-onset Pompe disease: an underdiagnosed treatable condition,” European Neurology, vol. 68, pp. 75–78, 2012. View at Google Scholar
  6. R. P. Morse and N. P. Rosman, “Diagnosis of occult muscular dystrophy: importance of the “chance” finding of elevated serum aminotransferase activities,” Journal of Pediatrics, vol. 122, no. 2, pp. 254–256, 1993. View at Google Scholar · View at Scopus
  7. H. G. Hers, “Alpha-Glucosidase deficiency in generalized glycogenstorage disease (Pompe's disease),” The Biochemical journal, vol. 86, pp. 11–16, 1963. View at Google Scholar · View at Scopus
  8. A. T. van der Ploeg, P. R. Clemens, D. Corzo et al., “A randomized study of alglucosidase alfa in late-onset Pompe's disease,” The New England Journal of Medicine, vol. 362, no. 15, pp. 1396–1406, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. H. J. Cilliers, S. T. Yeo, and N. P. Salmon, “Anaesthetic management of an obstetric patient with Pompe disease,” International Journal of Obstetric Anesthesia, vol. 17, no. 2, pp. 170–173, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Kalkum, D. Macchiella, J. Reinke, H. Kölbl, and M. Beck, “Enzyme replacement therapy with agalsidase alfa in pregnant women with Fabry disease,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 144, no. 1, pp. 92–93, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. J. M. Politei, “Treatment with agalsidase beta during pregnancy in Fabry disease,” Journal of Obstetrics and Gynaecology Research, vol. 36, no. 2, pp. 428–429, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. M. van de Velde, “Anaesthesia for caesarean section,” Current Opinion in Anaesthesiology, vol. 14, pp. 307–310, 2001. View at Google Scholar
  13. M. W. M. Rucklidge and M. J. Paech, “Limiting the dose of local anaesthetic for caesarean section under spinal anaesthesia: has the limbo bar been set too low?” Anaesthesia, vol. 67, no. 4, pp. 347–351, 2012. View at Publisher · View at Google Scholar · View at Scopus